Bioinformatics Partnering Terms and Agreements - Market Research

175 views

Published on

Bioinformatics Partnering Terms and Agreements @ http://www.researchmoz.us/bioinformatics-partnering-terms-and-agreements-report.html

The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies.

Published in: Technology, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
175
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Bioinformatics Partnering Terms and Agreements - Market Research

  1. 1. Bioinformatics Partnering Terms and Agreements The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for bioinformatics The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter bioinformatics partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right tlicense the licensors bioinformatics technology. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest bioinformatics agreements announced in the healthcare sectors. Bioinformatics is the application of computer science and information technology tthe field of biology and medicine. Bioinformatics deals with algorithms, databases, information systems, web technologies, artificial intelligence, information and computation theory, software engineering, data mining, image processing, modeling, simulation, signal processing, discrete mathematics, control systems, and statistics, for generating new knowledge of biology and medicine. Bioinformatics deals have increased in terms of popularity for partnering in the past decade, as computing power has been embraced in order tspeed up the discovery, evaluation and clinical assessment processes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight intthe negotiation process in terms of what you can expect tachieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases dnot. This report contains a comprehensive listing of all bioinformatics partnering deals announced since January 2007, including financial terms where available, including over 1700 links tonline deal records of actual bioinformatics partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted tthe Securities Exchange Commission by companies and their partners. The initial chapters of this report provide an orientation of bioinformatics dealmaking and business activities. Chapter 1 provides an introduction tthe report, whilst Chapter 2 provides an overview of the trends in bioinformatics dealmaking since 2007, including details of average headline, upfront, milestone and royalty terms. Chapter 3 provides a review of the leading bioinformatics deals since 2007. Deals are listed by headline value, signed by bigpharma, most active big pharma and big biotech, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access tthe contract. Bioinformatics Partnering Terms and Agreements
  2. 2. Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of bioinformatics deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink tan online version of the actual contract document, providing easy access teach contract document on demand. Chapter 5 provides a comprehensive listing of the top big biotech companies with a brief summary followed by a comprehensive listing of bioinformatics deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink tan online version of the actual contract document, providing easy access teach contract document on demand. Chapter 6 provides a comprehensive and detailed review of bioinformatics partnering deals signed and announced since January 2007, where a contract document is available in the public domain. The chapter is organized by stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand. In addition, a comprehensive appendix is provided organized by bioinformatics partnering company A-Z , deal type definitions and bioinformatics partnering agreements example. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand. The report alsincludes numerous tables and figures that illustrate the trends and activities in bioinformatics partnering and dealmaking since 2007. In conclusion, this report provides everything a prospective dealmaker needs tknow about partnering in the research, development and commercialization of bioinformatics technologies and products. Bioinformatics Partnering Terms and Agreements provides the reader with the following key benefits: In-depth understanding of bioinformatics deal trends since 2007 Access theadline, upfront, milestone and royalty data Analysis of the structure of bioinformatics agreements with numerous real life case studies Comprehensive access tover 1700 bioinformatics deals entered intby the world’s biopharma companies Detailed access tactual bioinformatics contracts enter intby the leading fifty bigpharma companies Insight intthe terms included in a bioinformatics agreement, together with real world clause examples Understand the key deal terms companies have agreed in previous deals Undertake due diligence tassess suitability of your proposed deal terms for partner companies Report scope Bioinformatics Partnering Terms and Agreements is intended tprovide the reader with an in-depth understanding and access tbioinformatics trends and structure of deals entered intby leading companies worldwide. Bioinformatics Partnering Terms and Agreements includes: Trends in bioinformatics dealmaking in the biopharma industry since 2007 Analysis of bioinformatics deal structure Access theadline, upfront, milestone and royalty data Case studies of real-life bioinformatics deals Access tover 1700 bioinformatics deal documents Access tcontract documents where available The leading bioinformatics deals by value since 2007 Most active bioinformatics dealmakers since 2007 The leading bioinformatics partnering resources In Bioinformatics Partnering Terms and Agreements, the available contracts are listed by: Company A-Z Headline value Stage of development at signing Deal component type Therapy target Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand. The Bioinformatics Partnering Terms Bioinformatics Partnering Terms and Agreements
  3. 3. and Agreements report provides comprehensive access tavailable deals and contract documents for over 1,500 bioinformatics deals. Analyzing actual contract agreements allows assessment of the following: What are the precise bioinformatics rights granted or optioned? What is actually granted by the agreement tthe partner company? What exclusivity is granted? What is the payment structure for the deal? How are sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Whis responsible for commercialization? Whis responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes tbe resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear tdiffer from partner tpartner or deal type tdeal type? Which jurisdiction does the company insist upon for agreement law? Bioinformatics Partnering Terms and Agreements provides the reader with the following key benefits: In-depth understanding of bioinformatics deal trends since 2007 Access theadline, upfront, milestone and royalty data Analysis of the structure of bioinformatics agreements with numerous real life case studies Comprehensive access tover 1700 bioinformatics deal documents entered intby the world’s biopharma companies Detailed access tactual bioinformatics contracts Provides insight intdeals dentered by top 50 big pharma and top big biotech companies Insight intthe terms included in a bioinformatics agreement, together with real world clause examples Understand the key deal terms companies have agreed in previous deals Undertake due diligence tassess suitability of your proposed deal terms for partner companies table Of Content executive Summary chapter 1 – Introduction chapter 2 – Trends In Bioinformatics Dealmaking 2.1. Introduction 2.2. Bioinformatics Partnering Over The Years 2.3. Big Pharma Bioinformatics Dealmaking Activity 2.4. Big Biotech Bioinformatics Dealmaking Activity 2.5. Most Active Bioinformatics Dealmakers 2.6. Bioinformatics Partnering By Deal Type 2.7. Bioinformatics Partnering By Stage Of Development 2.8. Bioinformatics Partnering By Disease Type 2.9. Average Deal Terms For Bioinformatics Partnering 2.9.1 Bioinformatics Partnering Headline Values 2.9.2 Bioinformatics Deal Upfront Payments 2.9.3 Bioinformatics Deal Milestone Payments 2.9.4 Bioinformatics Royalty Rates Bioinformatics Partnering Terms and Agreements
  4. 4. chapter 3 – Leading Bioinformatics Deals 3.1. Introduction 3.2. Top Bioinformatics Deals By Value 3.3. Top Bioinformatics Deals Involving Big Pharma chapter 4 – Bigpharma Bioinformatics Deals 4.1. Introduction 4.2. How To Use Bigpharma Bioinformatics Partnering Deals 4.3. Big Pharma Bioinformatics Partnering Company Profiles abbott allergan amgen astellas astrazeneca baxter International bayer biogen Idec boehringer Ingelheim bristol-myers Squibb csl daiichi Sankyo dainippon Sumitomo eisai eli Lilly galderma glaxosmithkline grifols hospira johnson & Johnson lundbeck merck & Co merck Kgaa mitsubishi Tanabe novartis novo Nordisk otsuka pfizer purdue roche sanofi Bioinformatics Partnering Terms and Agreements
  5. 5. servier shire takeda teva ucb valeant chapter 5 – Bigbiotech Bioinformatics Deals 5.1. Introduction 5.2. How To Use Big Biotech Partnering Deals 5.3. Big Biotech Bioinformatics Partnering Company Profiles array Biopharma dendreon elan galapagos genmab grifols ipsen novo Nordisk onyx Pharmaceuticals spectrum Pharmaceuticals vertex Pharmaceuticals chapter 6 – Bioinformatics Dealmaking Directory With Contracts 6.1. Introduction 6.2. By Stage Of Development discovery formulation marketed phase Iii 6.3. By Deal Type asset Purchase bigpharma Outlicensing collaborative R&d co-market contract Service co-promotion development distribution equity Purchase licensing Bioinformatics Partnering Terms and Agreements
  6. 6. litigation manufacturing marketing option promotion research settlement sub-license supply termination 6.4. By Therapy Area cardiovascular hematology hospital Care infectives oncology chapter 7 – Bioinformatics Dealmaking By Technology Type bioinformatics software Tools chapter 8 – Partnering Resource Center 8.1. Online Partnering 8.2. Partnering Events 8.3. Further Reading On Dealmaking about Wildwood Ventures current Partnering current Agreements recent Report Titles From Current Partnering order Form – Reports appendices appendix 1: By Company A-z appendix 2: By Stage Of Development Bioinformatics Partnering Terms and Agreements
  7. 7. appendix 3: By Deal Type appendix 4: By Therapy Area ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Bioinformatics Partnering Terms and Agreements

×